Adipose tissue dysregulation and metabolic consequences in childhood and adolescent obesity: Potential impact of dietary fat quality

Aoibheann McMorrow, Ruth Connaughton, Fiona LITHANDER, Helen Roche

    Research output: Contribution to journalArticle

    20 Citations (Scopus)

    Abstract

    Evidence suggests that at a population level, childhood and adolescent obesity increase the long-term risk of chronic diseases such as type 2 diabetes and CVD. At an individual level, however, the metabolic consequences of obesity in youth vary immensely. Despite comparable BMI, some adolescents develop impaired glucose tolerance while others maintain normal glucose homeostasis. It has been proposed that the variation in the capacity to store lipid in the subcutaneous adipose tissue (SAT) may partially discriminate metabolically healthy from unhealthy obesity. In positive energy balance, a decreased capacity to expand SAT may drive lipid accumulation to visceral adipose tissue, liver and skeletal muscle. This state of lipotoxicity is associated with chronic low-grade inflammation, insulin resistance and dyslipidaemia. The present review examines the differential adipose tissue development and function in children and adolescents who exhibit metabolic dysregulation compared with those who are protected. Additionally, the role of manipulating dietary fat quality to potentially prevent and treat metabolic dysfunction in obesity will be discussed. The findings of the present review highlight the need for further randomised controlled trials to establish the effect of dietary n-3 PUFA on the metabolic phenotype of obese children and adolescents. Furthermore, using a personalised nutrition approach to target interventions to those at risk of, or those with established metabolic dysregulation may optimise the efficacy of modifying dietary fat quality.
    Original languageEnglish
    Pages (from-to)67-82
    Number of pages16
    JournalProceedings of the Nutrition Society
    Volume74
    Issue number1
    DOIs
    Publication statusPublished - 2015

    Fingerprint

    Pediatric Obesity
    Dietary Fats
    Adipose Tissue
    Subcutaneous Fat
    Obesity
    Lipids
    Glucose Intolerance
    Intra-Abdominal Fat
    Omega-3 Fatty Acids
    Dyslipidemias
    Type 2 Diabetes Mellitus
    Insulin Resistance
    Skeletal Muscle
    Homeostasis
    Chronic Disease
    Randomized Controlled Trials
    Inflammation
    Phenotype
    Glucose
    Liver

    Cite this

    McMorrow, Aoibheann ; Connaughton, Ruth ; LITHANDER, Fiona ; Roche, Helen. / Adipose tissue dysregulation and metabolic consequences in childhood and adolescent obesity: Potential impact of dietary fat quality. In: Proceedings of the Nutrition Society. 2015 ; Vol. 74, No. 1. pp. 67-82.
    @article{1e01e20eddf645b582068137ebb54e2a,
    title = "Adipose tissue dysregulation and metabolic consequences in childhood and adolescent obesity: Potential impact of dietary fat quality",
    abstract = "Evidence suggests that at a population level, childhood and adolescent obesity increase the long-term risk of chronic diseases such as type 2 diabetes and CVD. At an individual level, however, the metabolic consequences of obesity in youth vary immensely. Despite comparable BMI, some adolescents develop impaired glucose tolerance while others maintain normal glucose homeostasis. It has been proposed that the variation in the capacity to store lipid in the subcutaneous adipose tissue (SAT) may partially discriminate metabolically healthy from unhealthy obesity. In positive energy balance, a decreased capacity to expand SAT may drive lipid accumulation to visceral adipose tissue, liver and skeletal muscle. This state of lipotoxicity is associated with chronic low-grade inflammation, insulin resistance and dyslipidaemia. The present review examines the differential adipose tissue development and function in children and adolescents who exhibit metabolic dysregulation compared with those who are protected. Additionally, the role of manipulating dietary fat quality to potentially prevent and treat metabolic dysfunction in obesity will be discussed. The findings of the present review highlight the need for further randomised controlled trials to establish the effect of dietary n-3 PUFA on the metabolic phenotype of obese children and adolescents. Furthermore, using a personalised nutrition approach to target interventions to those at risk of, or those with established metabolic dysregulation may optimise the efficacy of modifying dietary fat quality.",
    author = "Aoibheann McMorrow and Ruth Connaughton and Fiona LITHANDER and Helen Roche",
    year = "2015",
    doi = "10.1017/S002966511400158X",
    language = "English",
    volume = "74",
    pages = "67--82",
    journal = "Proceedings of the Nutrition Society",
    issn = "0029-6651",
    publisher = "Cambridge University Press",
    number = "1",

    }

    Adipose tissue dysregulation and metabolic consequences in childhood and adolescent obesity: Potential impact of dietary fat quality. / McMorrow, Aoibheann; Connaughton, Ruth; LITHANDER, Fiona; Roche, Helen.

    In: Proceedings of the Nutrition Society, Vol. 74, No. 1, 2015, p. 67-82.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Adipose tissue dysregulation and metabolic consequences in childhood and adolescent obesity: Potential impact of dietary fat quality

    AU - McMorrow, Aoibheann

    AU - Connaughton, Ruth

    AU - LITHANDER, Fiona

    AU - Roche, Helen

    PY - 2015

    Y1 - 2015

    N2 - Evidence suggests that at a population level, childhood and adolescent obesity increase the long-term risk of chronic diseases such as type 2 diabetes and CVD. At an individual level, however, the metabolic consequences of obesity in youth vary immensely. Despite comparable BMI, some adolescents develop impaired glucose tolerance while others maintain normal glucose homeostasis. It has been proposed that the variation in the capacity to store lipid in the subcutaneous adipose tissue (SAT) may partially discriminate metabolically healthy from unhealthy obesity. In positive energy balance, a decreased capacity to expand SAT may drive lipid accumulation to visceral adipose tissue, liver and skeletal muscle. This state of lipotoxicity is associated with chronic low-grade inflammation, insulin resistance and dyslipidaemia. The present review examines the differential adipose tissue development and function in children and adolescents who exhibit metabolic dysregulation compared with those who are protected. Additionally, the role of manipulating dietary fat quality to potentially prevent and treat metabolic dysfunction in obesity will be discussed. The findings of the present review highlight the need for further randomised controlled trials to establish the effect of dietary n-3 PUFA on the metabolic phenotype of obese children and adolescents. Furthermore, using a personalised nutrition approach to target interventions to those at risk of, or those with established metabolic dysregulation may optimise the efficacy of modifying dietary fat quality.

    AB - Evidence suggests that at a population level, childhood and adolescent obesity increase the long-term risk of chronic diseases such as type 2 diabetes and CVD. At an individual level, however, the metabolic consequences of obesity in youth vary immensely. Despite comparable BMI, some adolescents develop impaired glucose tolerance while others maintain normal glucose homeostasis. It has been proposed that the variation in the capacity to store lipid in the subcutaneous adipose tissue (SAT) may partially discriminate metabolically healthy from unhealthy obesity. In positive energy balance, a decreased capacity to expand SAT may drive lipid accumulation to visceral adipose tissue, liver and skeletal muscle. This state of lipotoxicity is associated with chronic low-grade inflammation, insulin resistance and dyslipidaemia. The present review examines the differential adipose tissue development and function in children and adolescents who exhibit metabolic dysregulation compared with those who are protected. Additionally, the role of manipulating dietary fat quality to potentially prevent and treat metabolic dysfunction in obesity will be discussed. The findings of the present review highlight the need for further randomised controlled trials to establish the effect of dietary n-3 PUFA on the metabolic phenotype of obese children and adolescents. Furthermore, using a personalised nutrition approach to target interventions to those at risk of, or those with established metabolic dysregulation may optimise the efficacy of modifying dietary fat quality.

    U2 - 10.1017/S002966511400158X

    DO - 10.1017/S002966511400158X

    M3 - Article

    VL - 74

    SP - 67

    EP - 82

    JO - Proceedings of the Nutrition Society

    JF - Proceedings of the Nutrition Society

    SN - 0029-6651

    IS - 1

    ER -